Axsome Therapeutics (AXSM) Buy Rating Reconfirmed at Cantor Fitzgerald; The Target is Set to $16; ESSILORLUXOTTICA AMERICAN DEPOSITARY REC (ESLOY) Shorts Lowered By 84.04% - Thе Mоnіtоr

Submitted by Anonymous (not verified) on Fri, 03/15/2019 - 13:29

Axsome Therapeutics (AXSM) Buy Rating Reconfirmed at Cantor Fitzgerald; The Target is Set to $16; ESSILORLUXOTTICA AMERICAN DEPOSITARY REC (ESLOY) Shorts Lowered By 84.04%  Thе MоnіtоrAxsome Therapeutics Inc (AXSM) Rating Analysts at Cantor Fitzgerald have $16 target price on Axsome Therapeutics Inc (AXSM). Cantor Fitzgerald's target ...